<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="39867">Valproic Acid</z:chebi> (VPA) in overdose is known to cause <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> with or without cerebral odema, hyperammonaemia, <z:e sem="disease" ids="C0235378,C0348754" disease_type="Disease or Syndrome;Injury or Poisoning" abbrv="">hepatotoxicity</z:e>, bone marrow suppression and non gap <z:hpo ids='HP_0001941'>acidosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Most of these conditions are reversible </plain></SENT>
<SENT sid="2" pm="."><plain>We report a 45-year-old man who suffered permanent disability from the non reversible effects of cerebral odema and infarctions associated with Valproate overdose which would have been aggravated by <z:chebi fb="11" ids="49575">Diazepam</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>This patient's presentation emphasizes the role of early detection and therapy of cerebral odema in Valproate and <z:chebi fb="11" ids="49575">Diazepam</z:chebi> overdose </plain></SENT>
</text></document>